Approved consistent with CDC response to OMB questions and comments.
Inventory as of this Action
Requested
Previously Approved
07/31/2009
24 Months From Approved
2,390
0
0
1,033
0
0
0
0
0
The Centers for Disease Control and Prevention (CDC) requests approval by the Office of Management and Budget (OMB) for a one-time collection of information to assess primary care physicians' attitudes and practices regarding prostate cancer screening. The survey will be conducted with a nationally representative sample of primary care physicians. The data collection is central to the prevention research agenda of the Division of Cancer Prevention and Control, CDC. Prostate cancer is the most commonly diagnosed cancer among men in the United States. In 2006, it is estimated that approximately 234,460 new cases of prostate cancer will be diagnosed and 27,350 men will die from the disease (American Cancer Society, 2006). Since prostate cancer in men is different from other cancers, major medical organizations are divided on whether men should be routinely screened for this disease. To date, no comprehensive national survey has been conducted to assess primary care physician attitudes and practices related to prostate cancer screening. The survey will be administered by mail to a random sample of about 3,000 primary care physicians; thereby (a) providing national estimates of physician use of PSA screening, (b) examining beliefs regarding the efficacy of prostate cancer screening and treatment, and (c) assessing the situations in which physicians recommend screening and using PSA and/or DRE as well as which guidelines they follow. CDC will use the results from this survey to examine the demographic, behavioral, attitudinal, and situational characteristics that influence physician's screening behaviors.
Primary care physicians include the specialties of family medicine, general practice, and general internal medicine. Primary care physicians in these specialties are likely to have a patient population of males age 40 and older. The sample will be stratified by race in order to allow race comparisons on attitudes and practices. Weighting the survey particpants by probability of selection will allow us to describe and generalize findings to the primary care population. Information gathered from a national survey will allow CDC, other researchers, and clinicians to: (1) examine how PSA testing, DRE, and prostate cancer screening follow-up are conducted in community practice across the Untied States, and (2) provide a valuable knowledge base to guide the development and implementation of interventions to improve primary care physician adherence to established prostate cancer screening guidelines in the United States. Conducting a nationally representative survey will allow the CDC to develop evidence-based materials likely to be more effective in supporting optimal clinical practice and helping providers to counsel patients regarding PSA testing.
Without this study, CDC would have limited knowledge of the variables that influence primary care physician practices regarding prostate cancer. It would be difficult for CDC to advise and inform states, other organizations that develop clinical training materials, physician decision support tools (such as informed decision making), and materials physicians use to manage, counsel and educate patients regarding prostate cancer and PSA screeening.
US Code:
42 USC 301
Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Screening for Survey of Primary Care Physicians Practices Regarding Prostate Cancer Screening
MD Survey Supporting Statement B and Bibliography.doc
Attachment 2. 60d FRN 2006.pdf
Screening for Survey of Primary Care Physicians Practices Regarding Prostate Cancer Screening